Back
Citius Pharmaceuticals Stock Price Chart
Could This Stock Under $5 Be Your Biggest Opportunity?
Click here to learn more.
Sell
34
CTXR
Citius Pharmaceuticals
Last Price:
$4.34
Seasonality Move:
26.36%
7 Day Trial
ALL ACCESS PASS
$
7
Stock Caught Trading Under Secret Name...
Find out more about the "hidden stock" here.-
The current trend is relatively stagnant and CTXR is experiencing selling pressure, which indicates risk of future bearish movement.
Citius Pharmaceuticals Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 3.73 | Buy |
| 20-day SMA: | 3.23 | Buy |
| 50-day SMA: | 5.45 | Sell |
| 200-day SMA: | 13.85 | Sell |
| 8-day EMA: | 3.71 | Buy |
| 20-day EMA: | 3.68 | Buy |
| 50-day EMA: | 5.43 | Sell |
| 200-day EMA: | 12.16 | Sell |
Citius Pharmaceuticals Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.33 | Sell |
| Relative Strength Index (14 RSI): | 48.89 | Sell |
| Chaikin Money Flow: | -59329 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (2.81 - 3.75) | Buy |
| Bollinger Bands (100): | (4.65 - 13.39) | Sell |
Citius Pharmaceuticals Technical Analysis
| Dec 20 | Dec 23 | Dec 24 | Dec 26 | Dec 27 | Dec 30 | Dec 31 | Jan 2 | Jan 3 | Jan 6 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | Jan | |||||||||
| 20 | 23 | 24 | 26 | 27 | 30 | 31 | 02 | 03 | 06 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Citius Pharmaceuticals Stock
Is Citius Pharmaceuticals Stock a Buy?
-
Citius Pharmaceuticals share price is 3.91 while CTXR 8-day simple moving average is 3.73, which is a Buy signal.
-
The stock price of CTXR is 3.91 while Citius Pharmaceuticals 20-day SMA is 3.23, which makes it a Buy.
-
Citius Pharmaceuticals 50-day simple moving average is 5.45 while CTXR share price is 3.91, making it a Sell technically.
-
CTXR stock price is 3.91 and Citius Pharmaceuticals 200-day simple moving average is 13.85, creating a Sell signal.
CTXR Technical Analysis vs Fundamental Analysis
Sell
34
Citius Pharmaceuticals (CTXR)
is a Sell
Is Citius Pharmaceuticals a Buy or a Sell?
-
Citius Pharmaceuticals stock is rated a SellThe current Citius Pharmaceuticals [CTXR] share price is $3.91. The Score for CTXR is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
Citius Pharmaceuticals Stock Info
Market Cap:
30.2M
Price in USD:
3.91
Share Volume:
102.1K
Citius Pharmaceuticals 52-Week Range
52-Week High:
26.75
52-Week Low:
2.44
Sell
34
Citius Pharmaceuticals (CTXR)
is a Sell
Citius Pharmaceuticals Share Price Forecast
-
What is the Citius Pharmaceuticals stock price today?The Citius Pharmaceuticals stock price is 3.91 USD today.
-
Will CTXR stock go up or go down?Citius Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators
-
Is Citius Pharmaceuticals overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Citius Pharmaceuticals is overvalued.
Is Citius Pharmaceuticals Stock a Buy?
-
Citius Pharmaceuticals share price is 3.91 while CTXR 8-day exponential moving average is 3.71, which is a Buy signal.
-
The stock price of CTXR is 3.91 while Citius Pharmaceuticals 20-day EMA is 3.68, which makes it a Buy.
-
Citius Pharmaceuticals 50-day exponential moving average is 5.43 while CTXR share price is 3.91, making it a Sell technically.
-
CTXR stock price is 3.91 and Citius Pharmaceuticals 200-day simple moving average is 12.16, creating a Sell signal.
Fundamental Analysis of Citius Pharmaceuticals
Is Citius Pharmaceuticals a good investment?
-
Analysts estimate an earnings increase this quarter of $0.25 per share, a decrease next quarter of $0.00 per share, an increase this year of $6.92 per share, and an increase next year of $1.21 per share.
Technical Analysis of Citius Pharmaceuticals
Should I short Citius Pharmaceuticals stock?
-
CTXR Moving Average Covergence Divergence (MACD) indicator is -0.33, suggesting Citius Pharmaceuticals is a Sell
-
Citius Pharmaceuticals Relative Strength Index (RSI) is 48.89, which suggest Citius Pharmaceuticals is oversold
-
The Bollinger Bands (25) for Citius Pharmaceuticals is (2.81 - 3.75), which suggest Citius Pharmaceuticals is a Sell
-
The Bollinger Bands (100) for Citius Pharmaceuticals is (4.65 - 13.39), which suggest Citius Pharmaceuticals is a Sell
* Citius Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.